LABB.MX

Healthcare Drug Manufacturers - Specialty & Generic

Genomma Lab Internacional, S.A.B. de C.V.

MX$12.83
+0.27 +2.15% today

Price History

Not enough data

Key Stats

Market Cap
12.54B
Avg Volume
3.29M
P/E (TTM)
7.72
EPS
MX$1.66
52W High
MX$19.48
52W Low
MX$12.22
Div. Yield
3.2%

Analyst Ratings

Buy
2
Str Buy
2
Buy
2
Hold
0
Sell
0
Str Sell

Valuation

Forward P/E
6.49
P/B Ratio
1.06
P/S Ratio
0.74
EV/EBITDA
4.60
EV/Revenue
1.05
PEG Ratio
0.47

Margins

Gross Margin 63.2%
Operating Margin 20.0%
Net Margin 9.6%
EBITDA Margin 22.9%

Growth & Returns

Revenue Growth (YoY)
(6.0%)
Earnings Growth (YoY)
3.9%
Earnings Growth (QoQ)
5.5%
Return on Equity
14.2%
Return on Assets
9.1%

Liquidity & Leverage

Current Ratio
1.41
Quick Ratio
1.13
Debt / Equity
0.67
Total Cash
2.41B
Total Debt
7.85B

About

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

www.genommalab.com